ClinicalTrials.Veeva

Menu

EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

R

Rennes University Hospital

Status

Unknown

Conditions

Multiple Sclerosis

Treatments

Other: clinical follow-up
Device: spinal cord MRI follow-up
Other: brain MRI follow-up

Study type

Interventional

Funder types

Other

Identifiers

NCT02117375
PHRC/12-07
2013-A00333-42

Details and patient eligibility

About

The purpose of this study is to evaluate the prognostic value of early focal lesions and early diffuse lesions on ambulatory disability progression within 5 years after clinical onset.

Full description

Prospective, multicentric study

Enrollment

115 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Patients with multiple sclerosis:

Inclusion Criteria:

  • Relapsing Remitting Multiple Sclerosis patients (Mac Donald 2010 criteria)
  • First clinical event < 1 year
  • Brain MRI > 9 lesions or/and spinal cord attack with focal lesion on spinal cord MRI
  • Score Expended Disability Status Scale < 3
  • Age between 18 and 40 years

Exclusion Criteria:

  • Multiple Sclerosis progressive
  • Patients treated with immunosuppressive therapy
  • Pregnancy

Healthy volunteers:

Inclusion Criteria:

-Age between 18 and 40 years

Exclusion Criteria:

-Pregnancy

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

115 participants in 2 patient groups

Patients with multiple sclerosis
Experimental group
Description:
80 patients / clinical Follow-up at M0, M6, M12, M18, M24, M30, M36, M42, M48, M54 and M60 / spinal cord MRI follow-up at M0, M12, M24, M36 and M60 / brain MRI follow-up at M0, M12, M24, M36 and M60
Treatment:
Device: spinal cord MRI follow-up
Other: clinical follow-up
Other: brain MRI follow-up
Healthy volunteers
Experimental group
Description:
20 healthy volunteers (stability of spinal cord imaging) / spinal cord MRI follow-up at M0 and M24
Treatment:
Device: spinal cord MRI follow-up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems